Overview
Clinical Meaning
Anemia is classified by three fundamental mechanisms: decreased RBC production (hypoproliferative), increased RBC destruction (hemolytic), and blood loss (acute or chronic).
AGPCNP
AGPCNP
Anemia is classified by three fundamental mechanisms: decreased RBC production (hypoproliferative), increased RBC destruction (hemolytic), and blood loss (acute or chronic). The reticulocyte production index (RPI) is the key discriminator — an RPI <2 indicates hypoproliferative anemia (the marrow is failing to compensate), while RPI >2 indicates appropriate marrow response to peripheral destruction or blood loss. Hypoproliferative anemias are further subclassified by MCV: microcytic (MCV <80 fL) suggests iron deficiency, thalassemia, sideroblastic anemia, or lead poisoning (mnemonic: TAILS); normocytic (MCV 80-100 fL) suggests anemia of chronic disease, CKD, aplastic anemia, or early iron/B12 deficiency; macrocytic (MCV >100 fL) suggests B12/folate deficiency (megaloblastic) or liver disease, hypothyroidism, myelodysplasia (non-megaloblastic). Hemolytic anemias are classified as intrinsic (RBC defects: membrane disorders like spherocytosis, enzyme defects like G6PD deficiency, hemoglobinopathies like sickle cell) versus extrinsic (immune-mediated autoimmune hemolytic anemia, microangiopathic hemolytic anemia in TTP/HUS/DIC, mechanical valves, infections). The hemolysis workup reveals elevated LDH, elevated indirect bilirubin, decreased haptoglobin (consumed binding free hemoglobin), elevated reticulocyte count, and schistocytes on peripheral smear in microangiopathic processes.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this AGPCNP pathway. You can still explore topic-filtered questions from the bank hubs below.